In market activity today, shares of Knight Therapeutics Inc opened at $5.88 and closed at $5.76. prices ranged from $5.72 to $5.88.

Share prices advanced 1.05 percent from the previous day's close of $5.70.

Today across North America, the TSX Composite closed -0.95% at 21899.99, the S&P 500 closed -1.46% at 5123.41, the Dow Jones Industrial Average closed -1.24% at 37983.24 and the Nasdaq Composite closed -1.62% at 16175.09.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

A total of 69,390 shares was traded during the session, with total trades of 347, while having an average volume of 88,568 in the last five days.

The TSX market on the whole today saw 939 price advancers against 4,327 declines and 94 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $5.95 (April 11,2024) and low as $4.35 (October 23,2023). Moreover, in the last 12 months, Knight Therapeutics Inc's shares have advanced 19.75%, while they have advanced 10.98% this year.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $576.67 million on a float of 101,170 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Knight Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..